Figure 5
Figure 5. OS of 41 AML patients treated with intensive induction chemotherapy with Ara-C, anthracycline, and a third agent (flavopiridol or etoposide): stratification by high versus low 2-gene ratio. Median ratio = 0.959. HR indicates hazard ratio.

OS of 41 AML patients treated with intensive induction chemotherapy with Ara-C, anthracycline, and a third agent (flavopiridol or etoposide): stratification by high versus low 2-gene ratio. Median ratio = 0.959. HR indicates hazard ratio.

Close Modal

or Create an Account

Close Modal
Close Modal